• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

协调性心脏肥大和血管生成的破坏促成了向心力衰竭的转变。

Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.

作者信息

Shiojima Ichiro, Sato Kaori, Izumiya Yasuhiro, Schiekofer Stephan, Ito Masahiro, Liao Ronglih, Colucci Wilson S, Walsh Kenneth

机构信息

Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts 02118, USA.

出版信息

J Clin Invest. 2005 Aug;115(8):2108-18. doi: 10.1172/JCI24682.

DOI:10.1172/JCI24682
PMID:16075055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1180541/
Abstract

Although increased external load initially induces cardiac hypertrophy with preserved contractility, sustained overload eventually leads to heart failure through poorly understood mechanisms. Here we describe a conditional transgenic system in mice characterized by the sequential development of adaptive cardiac hypertrophy with preserved contractility in the acute phase and dilated cardiomyopathy in the chronic phase following the induction of an activated Akt1 gene in the heart. Coronary angiogenesis was enhanced during the acute phase of adaptive cardiac growth but reduced as hearts underwent pathological remodeling. Enhanced angiogenesis in the acute phase was associated with mammalian target of rapamycin-dependent induction of myocardial VEGF and angiopoietin-2 expression. Inhibition of angiogenesis by a decoy VEGF receptor in the acute phase led to decreased capillary density, contractile dysfunction, and impaired cardiac growth. Thus, both heart size and cardiac function are angiogenesis dependent, and disruption of coordinated tissue growth and angiogenesis in the heart contributes to the progression from adaptive cardiac hypertrophy to heart failure.

摘要

尽管增加的外部负荷最初会诱导心脏肥大且收缩力保持不变,但持续的超负荷最终会通过尚不清楚的机制导致心力衰竭。在此,我们描述了一种小鼠条件转基因系统,其特征是在心脏中诱导激活的Akt1基因后,急性期出现适应性心脏肥大且收缩力保持不变,慢性期则发展为扩张型心肌病。在适应性心脏生长的急性期,冠状动脉血管生成增强,但随着心脏发生病理重塑而减少。急性期血管生成增强与雷帕霉素哺乳动物靶标依赖性诱导心肌VEGF和血管生成素-2表达有关。在急性期用诱饵VEGF受体抑制血管生成会导致毛细血管密度降低、收缩功能障碍和心脏生长受损。因此,心脏大小和心脏功能均依赖于血管生成,心脏中协调的组织生长和血管生成的破坏有助于从适应性心脏肥大发展为心力衰竭。

相似文献

1
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.协调性心脏肥大和血管生成的破坏促成了向心力衰竭的转变。
J Clin Invest. 2005 Aug;115(8):2108-18. doi: 10.1172/JCI24682.
2
Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.脂联素缺乏通过破坏 AMPK 依赖性血管生成反应加重压力超负荷后的心脏功能障碍。
J Mol Cell Cardiol. 2010 Aug;49(2):210-20. doi: 10.1016/j.yjmcc.2010.02.021. Epub 2010 Mar 4.
3
Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy.心脏中Akt3的过表达会导致从适应性肥大向病理性肥大的进展。
J Mol Cell Cardiol. 2005 Feb;38(2):375-85. doi: 10.1016/j.yjmcc.2004.12.002. Epub 2005 Jan 25.
4
Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.血管内皮生长因子阻断会阻止β受体阻滞剂治疗心力衰竭对心功能、血管生成和重构的有益作用。
Circ Heart Fail. 2013 Nov;6(6):1259-67. doi: 10.1161/CIRCHEARTFAILURE.113.000329. Epub 2013 Sep 12.
5
Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.内皮素瘦素受体缺失通过抑制 Akt/mTOR 信号通路促进压力超负荷后的心脏自噬和血管生成。
Circ Heart Fail. 2019 Jan;12(1):e005622. doi: 10.1161/CIRCHEARTFAILURE.118.005622.
6
Distinct functions of junD in cardiac hypertrophy and heart failure.JunD在心肌肥大和心力衰竭中的不同功能。
Genes Dev. 2005 Jan 15;19(2):208-13. doi: 10.1101/gad.327005.
7
The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure.CaMKII的deltaC亚型在心肌肥大中被激活,并诱发扩张型心肌病和心力衰竭。
Circ Res. 2003 May 2;92(8):912-9. doi: 10.1161/01.RES.0000069686.31472.C5. Epub 2003 Apr 3.
8
Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure.从小鼠心脏中靶向消融整合素连接激酶(ILK)会导致扩张型心肌病和自发性心力衰竭。
Genes Dev. 2006 Sep 1;20(17):2355-60. doi: 10.1101/gad.1458906.
9
Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure.对转基因小鼠心脏中Akt1激活的微阵列分析揭示了与代偿性肥大和衰竭相关的转录本表达谱。
Physiol Genomics. 2006 Oct 11;27(2):156-70. doi: 10.1152/physiolgenomics.00234.2005. Epub 2006 Aug 1.
10
Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload.肌联蛋白在心内的过表达可预防因长期压力超负荷引起的扩张型心肌病。
Circ Res. 2005 May 27;96(10):1087-94. doi: 10.1161/01.RES.0000168028.36081.e0. Epub 2005 Apr 28.

引用本文的文献

1
Transcriptional meta-analysis and immune cell profiles reveal altered neutrophil dynamics in chronic atrial fibrillation.转录元分析和免疫细胞图谱揭示慢性心房颤动中中性粒细胞动力学的改变。
R Soc Open Sci. 2025 Mar 5;12(3):241102. doi: 10.1098/rsos.241102. eCollection 2025 Mar.
2
Novel model of cardiac hypertrophy with cardiorenal dysfunction.伴有心肾功能障碍的新型心脏肥大模型。
Sci Rep. 2025 Jul 19;15(1):26242. doi: 10.1038/s41598-025-90435-z.
3
Semaphorin 3F is elevated in serum of heart failure patients and inhibits cardiac angiogenesis via the VEGF/Akt/eNOS pathway.信号素3F在心力衰竭患者血清中升高,并通过VEGF/Akt/eNOS途径抑制心脏血管生成。
J Mol Cell Cardiol Plus. 2025 Jun 25;13:100470. doi: 10.1016/j.jmccpl.2025.100470. eCollection 2025 Sep.
4
High burden of premature ventricular contractions upregulates transcriptional markers of inflammation and promotes adverse cardiac remodeling linked to cardiomyopathy.室性早搏的高负担会上调炎症转录标志物,并促进与心肌病相关的不良心脏重塑。
bioRxiv. 2025 May 28:2025.05.23.652709. doi: 10.1101/2025.05.23.652709.
5
Molecular Mechanisms of Type 2 Diabetes-Related Heart Disease and Therapeutic Insights.2型糖尿病相关心脏病的分子机制及治疗见解
Int J Mol Sci. 2025 May 9;26(10):4548. doi: 10.3390/ijms26104548.
6
A biodegradable, microstructured, electroconductive and nano-integrated drug eluting patch (MENDEP) for myocardial tissue engineering.一种用于心肌组织工程的可生物降解、微结构化、导电且纳米集成的药物洗脱贴片(MENDEP)。
Bioact Mater. 2025 Apr 14;50:246-272. doi: 10.1016/j.bioactmat.2025.04.008. eCollection 2025 Aug.
7
Comprehensive review of non-invasive-treatment-related cardiovascular toxicity in breast cancer.乳腺癌非侵入性治疗相关心血管毒性的综合综述
iScience. 2025 Jan 4;28(4):111759. doi: 10.1016/j.isci.2025.111759. eCollection 2025 Apr 18.
8
Enhancement of mitochondrial calcium uptake is cardioprotective against maladaptive hypertrophy by retrograde signaling uptuning Akt.增强线粒体钙摄取通过逆行信号上调Akt对适应性不良性肥大具有心脏保护作用。
Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2402639122. doi: 10.1073/pnas.2402639122. Epub 2025 Mar 11.
9
Active ingredients of traditional Chinese medicine inhibit NOD-like receptor protein 3 inflammasome: a novel strategy for preventing and treating heart failure.中药活性成分抑制NOD样受体蛋白3炎性小体:一种防治心力衰竭的新策略。
Front Immunol. 2025 Jan 24;16:1520482. doi: 10.3389/fimmu.2025.1520482. eCollection 2025.
10
Single-Cell Transcriptomic Reveals the Involvement of Cell-Cell Junctions in the Early Development of Hypertrophic Cardiomyopathy.单细胞转录组学揭示细胞间连接在肥厚型心肌病早期发展中的作用。
J Cell Mol Med. 2025 Feb;29(3):e70366. doi: 10.1111/jcmm.70366.

本文引用的文献

1
The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.FOXO3a转录因子在AKT信号传导下游调节心肌细胞大小。
J Biol Chem. 2005 May 27;280(21):20814-23. doi: 10.1074/jbc.M500528200. Epub 2005 Mar 21.
2
Loaded wheel running and muscle adaptation in the mouse.小鼠负重轮运动与肌肉适应
Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H455-65. doi: 10.1152/ajpheart.00085.2005. Epub 2005 Feb 25.
3
Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy.心脏中Akt3的过表达会导致从适应性肥大向病理性肥大的进展。
J Mol Cell Cardiol. 2005 Feb;38(2):375-85. doi: 10.1016/j.yjmcc.2004.12.002. Epub 2005 Jan 25.
4
Genentech discloses safety concerns over Avastin.基因泰克公司披露了对阿瓦斯汀安全性的担忧。
Nat Biotechnol. 2004 Oct;22(10):1198. doi: 10.1038/nbt1004-1198.
5
Sex modifies exercise and cardiac adaptation in mice.性别会改变小鼠的运动和心脏适应性。
Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2768-76. doi: 10.1152/ajpheart.00292.2004. Epub 2004 Aug 19.
6
Deletion of ribosomal S6 kinases does not attenuate pathological, physiological, or insulin-like growth factor 1 receptor-phosphoinositide 3-kinase-induced cardiac hypertrophy.核糖体S6激酶的缺失并不会减弱病理性、生理性或胰岛素样生长因子1受体-磷酸肌醇3激酶诱导的心脏肥大。
Mol Cell Biol. 2004 Jul;24(14):6231-40. doi: 10.1128/MCB.24.14.6231-6240.2004.
7
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.用雷帕霉素抑制mTOR信号通路可使由压力超负荷诱导的已形成的心脏肥大消退。
Circulation. 2004 Jun 22;109(24):3050-5. doi: 10.1161/01.CIR.0000130641.08705.45. Epub 2004 Jun 7.
8
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.贝伐单抗(一种用于治疗癌症的抗血管内皮生长因子抗体)的发现与研发。
Nat Rev Drug Discov. 2004 May;3(5):391-400. doi: 10.1038/nrd1381.
9
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes.Akt的核靶向作用增强了心肌细胞的激酶活性和存活率。
Circ Res. 2004 Apr 16;94(7):884-91. doi: 10.1161/01.RES.0000124394.01180.BE. Epub 2004 Feb 26.
10
TOR signaling.TOR信号传导
Sci STKE. 2003 Dec 9;2003(212):re15. doi: 10.1126/stke.2122003re15.